ClinicalTrials.gg
Sign In

Skin Neoplasms clinical trials

The registry lists 604 studies for Skin Neoplasms across more than 10 countries. 126 are recruiting or about to start. 253 of them are mainly about Skin Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 7 narrower conditions too, such as Melanoma: 4,007 studies, 709 open.

ClinicalTrials.gov finds 19,561 studies for Skin Neoplasms. How that becomes 605 here

This page counts the studies the registry files under Skin Neoplasms, and those it files under no condition that list Skin Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 19,561Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −3,058Filed under a narrower condition, counted on its own pageMelanoma 2,991 · Blastic Plasmacytoid Dendritic Cell Neoplasm 45 · Basal Cell Nevus Syndrome 10 · Dysplastic Nevus Syndrome 5 · Uveal Melanoma 5
  3. −49List Skin Neoplasms as a condition, but the registry did not file them under itMost often written as “Non-melanoma Skin Cancer” (14), “Non-melanomatous Skin Cancer” (13), and “Skin Cancer Face” (6). The registry filed them under other conditions only, most often Carcinoma, Basal Cell (22) and Keratosis, Actinic (8).
  4. −15,849Match it another way52 name it in the title, 12 in a keyword, and 15,785 by a synonym or other text the search reads.
  5. 605The count on this page41 of them list Skin Neoplasms in their own words; the registry filed them under no condition.

Get an email when these change. Save the Skin Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
294
Recruiting
104
Terminated
67
Active, not recruiting
49
Status unknown
40
Withdrawn
25

Phase

Phase 2
143
Phase 1
89
Phase 3
33
Phase 4
17
Early Phase 1
17

Where

United States
379
United Kingdom
40
France
40
Australia
36
Germany
31
Canada
28

Who runs them

National Cancer Institute (NCI) (33) · H. Lee Moffitt Cancer Center and Research Institute (19) · M.D. Anderson Cancer Center (12) · Massachusetts General Hospital (11) · Alpha Tau Medical LTD. (11) · Memorial Sloan Kettering Cancer Center (11) · Northwestern University (10) · Stanford University (10)

What is being tested here

Drugs under test in Skin Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cemiplimab619
Nivolumab317
Ipilimumab218
Pembrolizumab205
Lifileucel213
Niacinamide202
Aminolevulinic Acid106
HhAntag691103
Cosibelimab102
Suzetrigine101

Drug classes tested here Immune checkpoint inhibitors 12 open · Antimitotic agents 1 open · Tyrosine kinase inhibitors (TKIs) 17 · Alkylating agents 9 · Antimetabolites 7

Coming up

10phase 3 studies under way
56studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 104 Skin Neoplasms studies recruiting now, 84 (81%) set no upper age limit and 9 (9%) stop at 75 or younger. 15 (14%) take children under 18. 1 (1%) are for women only and 0 (0%) for men only; 25 (24%) take healthy volunteers.

Recruiting studies that take each age, of 104
AgeWomenMen
1010 (10%)9 (9%)
1899 (95%)98 (94%)
30100 (96%)99 (95%)
40100 (96%)99 (95%)
5099 (95%)99 (95%)
6598 (94%)98 (94%)
7595 (91%)95 (91%)
8594 (90%)94 (90%)

Across all 604 studies, recruiting or not: 10% stop at 75 or younger and 6% at 65; 15% take children; 2% are for women only and 1% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Skin Neoplasms studies take

Of 36 phase 1 interventional studies under Skin Neoplasms, half reached primary completion within 49 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 149 mo28–57 · 36 studies——
Phase 260 mo35–97 · 34 studies——
Interventional, no phase27 mo10–66 · 116 studies—23 mo9–49 · 94 studies
Observational72 mo21–248 · 78 studies—139 mo24–… · 53 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Stopped2

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 604. Browse all 604 → or search them.